Downregulated lncRNA SLC7A11-AS1 inhibits miR-33a-5p, resulting in increased expression of xCT and GSH levels, which reduces ROS and enhances cisplatin resistance in GC [195]. This evidence concerns the gene SLC7A11 and gastric cancer.